SpaceX Lockup Release Stokes Supply Concerns

SpaceX lockup release prompted investor concern on Sept. 24, 2026, after reports that a large tranche of Class A shares became eligible for transfer and a reported Gwynne Shotwell Form 144 raised near-term supply questions for SPCX.

Lockup Expirations Increase Share Supply

Up to 328.4 million Class A shares became eligible for transfer or sale on Sept. 24, 2026, under SpaceX’s staggered IPO lockup schedule, representing about 7% of the locked pool. Additional tranches of roughly 328 million shares were scheduled for Oct. 9 and Oct. 24, followed by a potential release of up to 1.3 billion shares after third-quarter results.

The expiration of a lockup removes contractual transfer restrictions but does not require holders to sell. Potential sellers include early investors, employees, and other restricted holders. Elon Musk’s roughly 6.4 billion shares, about half the company, remain subject to a separate lockup until June 2027, limiting near-term free float.

Insider Filing and Trading Plan

A Gwynne Shotwell Form 144 dated Sept. 22, 2026, covered a proposed sale of 342,170 shares valued at about $52 million. The sale was reportedly made under a Rule 10b5-1 trading plan adopted June 23, 2026, which covered up to 585,605 shares. The shares were acquired through a cash exercise of stock options.

Valuation Debate Continues

Analysts remain divided on SpaceX’s valuation and long-term prospects, with coverage presenting both bullish growth narratives and skeptical price-sensitive scenarios. Reports describe the company as operating three growth-oriented business units, informing contrasting valuation frameworks.

The staged unlock schedule and the insider filing are likely to keep supply and valuation discussions active through autumn and into the post-third-quarter period.